Tag: monotherapy
U.S. halts distribution of Eli Lilly’s coronavirus antibody treatment bamlanivimab as a monotherapy
The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab (LY-CoV555) as a monotherapy just four months after it received FDA emergency use authorization, citing a sustained increase in variants of SARS-CoV-2 that are resistant to the monotherapy. More...